A mutated intron sequence codes for an antigenic peptide recognized by cytolytic T lymphocytes on a human melanoma.
about
A new antigen recognized by cytolytic T lymphocytes on a human kidney tumor results from reverse strand transcriptionRegulation of chromatin architecture by the PWWP domain-containing DNA damage-responsive factor EXPAND1/MUM1Translation of a retained intron in tyrosinase-related protein (TRP) 2 mRNA generates a new cytotoxic T lymphocyte (CTL)-defined and shared human melanoma antigen not expressed in normal cells of the melanocytic lineageIdentification of TRP-2 as a human tumor antigen recognized by cytotoxic T lymphocytesIdentification of a polymorphic gene, BCL2A1, encoding two novel hematopoietic lineage-specific minor histocompatibility antigensHuman tumor antigens recognized by T lymphocytesSafety of targeting tumor endothelial cell antigensIdentifying Individual T Cell Receptors of Optimal Avidity for Tumor AntigensBioinformatics for cancer immunology and immunotherapyDatabase of T cell-defined human tumor antigens: the 2013 updateDNA vaccine for cancer immunotherapyPRAME, a gene encoding an antigen recognized on a human melanoma by cytolytic T cells, is expressed in acute leukaemia cellsPre-existing immunity to tyrosinase-related protein (TRP)-2, a new TRP-2 isoform, and the NY-ESO-1 melanoma antigen in a patient with a dramatic response to immunotherapyPhotodynamic therapy of tumors can lead to development of systemic antigen-specific immune responseIdentification of Glycopeptides as Posttranslationally Modified Neoantigens in Leukemia.The immunodominant antigen of an ultraviolet-induced regressor tumor is generated by a somatic point mutation in the DEAD box helicase p68The immunodominant major histocompatibility complex class I-restricted antigen of a murine colon tumor derives from an endogenous retroviral gene productTumor antigens and tumor vaccines: peptides as immunogens.Simultaneous humoral and cellular immune response against cancer-testis antigen NY-ESO-1: definition of human histocompatibility leukocyte antigen (HLA)-A2-binding peptide epitopes.Mining the mutanome: developing highly personalized Immunotherapies based on mutational analysis of tumorsBioactivity of autologous irradiated renal cell carcinoma vaccines generated by ex vivo granulocyte-macrophage colony-stimulating factor gene transfer.The role of tumour heterogeneity and clonal cooperativity in metastasis, immune evasion and clinical outcomeImmunologic approaches to antigen discovery for cancer vaccines.Heat shock proteins: the fountainhead of innate and adaptive immune responses.Phase I clinical trial of the vaccination for the patients with metastatic melanoma using gp100-derived epitope peptide restricted to HLA-A*2402.An antigenic peptide produced by reverse splicing and double asparagine deamidationAlternative translational reading frames as a novel source of epitopes for an expanded CD8 T-cell repertoire: use of a retroviral system to assess the translational requirements for CTL recognition and lysis.Immune responses to tumour antigens: implications for antigen specific immunotherapy of cancer.Translation of pre-spliced RNAs in the nuclear compartment generates peptides for the MHC class I pathwayImmune response after photodynamic therapy increases anti-cancer and anti-bacterial effects.The 53BP1-EXPAND1 connection in chromatin structure regulation.Peptide vaccines for cancer.Immunotherapy for melanoma.Cancer immunotherapy with peptide-based vaccines: what have we achieved? Where are we going?Stimulation of anti-tumor immunity by photodynamic therapyNon-conventional sources of peptides presented by MHC class I.Tumor antigens and proteomics from the point of view of the major histocompatibility complex peptides.Melacine: an allogeneic melanoma tumor cell lysate vaccine.Induction of primary NY-ESO-1 immunity: CD8+ T lymphocyte and antibody responses in peptide-vaccinated patients with NY-ESO-1+ cancers.MHC-bound antigens and proteomics for novel target discovery.
P2860
Q22010943-33EA6019-0CB5-4497-A2C4-0F36222B5498Q24304951-B49194EE-1A35-487E-B1B2-39D99AA035B5Q24646800-5EFC21AE-47CE-4F00-A150-8869C305A40EQ24647904-DC908832-53F9-4803-915A-6050D15AE301Q24673417-AD2E1A30-C852-4BC3-ACCA-3B7FFF22BE43Q24678508-E3F0B7F3-EFA0-4ECC-8696-031B801C5984Q26748863-FF32FD4B-E165-46DD-B320-58A41D1BAAEEQ26774669-70604294-6933-44D2-8AAE-C6366107C5F8Q26864876-D9E56EEB-C92D-478B-A6AB-D74BF7B5EDAEQ27022422-FDA5DC6C-B418-471A-ADCC-E07F9FECC329Q28080919-888E487B-C64F-447C-8EFD-807998B3B89BQ28283719-E144ACFE-3079-4C9E-83A2-898288B1CE77Q28344557-D2CCC1A2-3C20-4D6E-91C6-97BFC8028E5EQ28744245-945217A6-1319-4EF3-9F9E-66F4D21098BFQ30252929-394E915F-B1B8-493D-B4ED-69E4BD306FF8Q30442838-FB0AC07E-7FE8-44BC-9813-F5969A5531EEQ30453892-BDB12E2E-789B-4A79-AE7E-6E2B9D9A3090Q30469630-55971556-76C8-43D4-AC53-8BBCA7C125EDQ32142930-136E333F-C841-425A-83C9-05251036275BQ33606161-D2C751DB-6483-45C4-95C1-42F243D01477Q33854375-6761E33E-4786-4199-B409-8506F494B2EAQ33913152-FB892976-CDE1-482B-9734-4FB9B91D3E83Q34074742-5A8AA42F-9429-49B5-99D3-3A7303EF7E3BQ34145113-1A815FBD-6405-46BD-AF93-6181393A968DQ34173622-90CE02C0-2FBC-4F33-BA9E-D014C2ED9C6CQ34192290-F27EAD75-5510-4BDC-82CA-C81D1EBA74EDQ34347168-D0510EEC-05CD-4B41-B086-F116071A14A2Q34353878-5C5608EB-61B0-467D-A7F3-36C3853EC2CDQ34374454-50A10AD2-A3F6-42E2-ADEA-CC83A6604491Q34429312-A11A05E4-E68D-47FE-8CEF-D5AC849067BAQ34521556-D944C303-A1FC-4AE9-AB11-4C9317D85E4CQ34568992-BB753235-0BEB-44D1-896E-A02EC0DF1F53Q34573035-58154BF8-51B6-46AC-B79E-AB4B76FA4EFBQ34669820-AEEA4291-F913-4215-9874-E61BCF51631BQ34697795-FFE919C4-AC54-4155-AECA-AC744137A8A6Q34768462-29BC3D81-128E-4BDA-AF5D-37FDF3B404BBQ35160569-1F9C371D-C67C-4687-9A59-9144EB4C1EE3Q35194168-8F8CB85B-EED7-445A-9C26-0BC2B12B3F82Q35403688-8435BCC1-119D-4F3F-B1BD-047717EAA9C4Q35911151-7DE89793-D801-440F-B749-46EDDB762D44
P2860
A mutated intron sequence codes for an antigenic peptide recognized by cytolytic T lymphocytes on a human melanoma.
description
1995 nî lūn-bûn
@nan
1995 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
A mutated intron sequence code ...... mphocytes on a human melanoma.
@ast
A mutated intron sequence code ...... mphocytes on a human melanoma.
@en
A mutated intron sequence code ...... mphocytes on a human melanoma.
@nl
type
label
A mutated intron sequence code ...... mphocytes on a human melanoma.
@ast
A mutated intron sequence code ...... mphocytes on a human melanoma.
@en
A mutated intron sequence code ...... mphocytes on a human melanoma.
@nl
prefLabel
A mutated intron sequence code ...... mphocytes on a human melanoma.
@ast
A mutated intron sequence code ...... mphocytes on a human melanoma.
@en
A mutated intron sequence code ...... mphocytes on a human melanoma.
@nl
P2093
P2860
P356
P1476
A mutated intron sequence code ...... mphocytes on a human melanoma.
@en
P2093
Andrawiss M
P2860
P304
P356
10.1073/PNAS.92.17.7976
P407
P577
1995-08-01T00:00:00Z